✦ LIBER ✦

A phase I study of sequential gemcitabine and MTA (LY231514) in patients with advanced malignancies

✍ Scribed by A. Adjei; C. Erlichman; H. Pitot; J. Sloan; R. Goldberg; P. Peethambaram; L. Hanson; J. Reid; R. Johnson

Book ID: 117667718
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 138 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)81177-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of MTA (multi-targeted a

A phase I study of MTA (multi-targeted antifolate, LY231514) plus cisplatin (CIS) in patients with advanced solid tumours

✍ Thoedtmann, R.; Kemmerich, M.; Depenbrock, H.; Blatter, J.; Ohnmacht, U.; Rastet 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 285 KB

MTA (LY231514) demonstrates clinical act

MTA (LY231514) demonstrates clinical activity against malignant mesothelioma in a phase I combination trial with carboplatin

✍ Calvert, A.H.; Hughes, A.N.; Calvert, P.M.; Plummer, R.E.; Highley, M.S. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Phase I study of pegylated liposomal dox

Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies

✍ Paula M. Fracasso; Kristie A. Blum; Benjamin R. Tan; Carole L. Fears; Nancy L. B 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

## Abstract ## BACKGROUND Pegylated liposomal doxorubicin (PEG‐LD) and gemcitabine have single‐agent activity in breast and ovarian carcinoma patients. We conducted a Phase I trial to evaluate the maximum tolerated dose (MTD) and toxicities of this combination in patients with advanced malignancie

A phase I study of the multitargeted ant

A phase I study of the multitargeted antifolate (MTA) (LY 231514) in combination with oxaliplatin (LOHP) in metastatic solid tumors

✍ Fumoleau, P.; Gamelin, E.; Misset, J.-L.; Delaloge, S.; Ripoche, V.; Kayitalire, 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Phase I study of oral gemcitabine prodru

Phase I study of oral gemcitabine prodrug (LY2334737) in Japanese patients with advanced solid tumors

✍ Noboru Yamamoto, Hiroshi Nokihara, Yasuhide Yamada… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 294 KB

Phase I Study of Eniluracil, Oral 5-Fluo

Phase I Study of Eniluracil, Oral 5-Fluororacil and Gemcitabine in Patients with Advanced Malignancy

✍ Sherry Morgan-Meadows; James P. Thomas; Daniel Mulkerin; Jordan D. Berlin; Howar 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 63 KB